SWM
AVXL icon

SeaCrest Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

SeaCrest Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,700
Closed -$182K – 633
2025
Q2 		$182K Buy
19,700
+2,100
+12% +$17.9K 0.02% 588
2025
Q1 		$151K Buy
17,600
+2,300
+15% +$21.7K 0.02% 635
2024
Q4 		$164K Buy
+15,300
New +$118K 0.02% 628
2022
Q3 		– Sell
-4,375
Closed -$44K – 691
2022
Q2 		$44K Buy
+4,375
New +$41.4K 0.01% 1171
2022
Q1 		– Sell
-13,075
Closed -$227K – 717
2021
Q4 		$227K Sell
13,075
-1,400
-10% -$26.6K 0.02% 604
2021
Q3 		$260K Buy
14,475
+650
+5% +$12.9K 0.03% 533
2021
Q2 		$316K Buy
+13,825
New +$205K 0.04% 484

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return